Objective

This annual conference will bring legal practitioners working with the pharmaceutical sector up-to-date on the latest relevant regulatory developments, legislative initiatives and case law.

Key topics

• Impact of recent rulings from the CJEU on SPCs, access to data, orphan designations
• Ongoing European Commission and national cases on competition law, generic and biosimilar drugs Recent legal developments on patent extensions
• Medical and clinical trials data
• Personal data in the big data world
• Recent EU initiatives on orphan drugs
• International and EU developments on HTA
• Pricing policies in Europe
• EU pharmaceutical law round-up

Who should attend?

In-house counsel, lawyers in private practice, lawyers in national ministries and authorities dealing with regulation of the sector.